Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Corticosteroid Injection - 80mg methylprednisolone (total volume 2ml) with 6 mL of 1% Bupivacaine without epinephrine (Total Volume 8 mL).

Preclinical

UUnity Health Toronto

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Total Knee AnthroplastyRecruiting

Total Knee AnthroplastyPreclinical

Recruiting

Timeline

Expected Milestones

Q3 2027

PreclinicalRecruiting

Total Knee Anthroplasty

NCT06809998

Clinical

Trials by Indication[1]

Total Knee Anthroplasty1 trial

COSTI: COntralateral CorticoSTeroid Injection in Total Knee Arthroplasty - A Triple Blinded, Randomized Controlled Trial Pilot Study

Recruiting·UUnity Health Toronto·Preclinical·NCT06809998·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Corticosteroid Injection - 80mg methylprednisolone (total volume 2ml) with 6 mL of 1% Bupivacaine without epinephrine (Total Volume 8 mL).. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Corticosteroid Injection - 80mg methylprednisolone (total volume 2ml) with 6 mL of 1% Bupivacaine without epinephrine (Total Volume 8 mL).. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Unity Health Toronto company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: UUnity Health Toronto

Related News